NASDAQ:ITEK
Delisted

Inotek Pharmaceuticals Corporation Fund Forecast

$3.04
+0 (+0%)
At Close: Jan 22, 2018
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Inotek Pharmaceuticals Corporation fund price ended at $3.04 on Monday, after losing 0%.
(Updated on Jan 22, 2018)

Buy or Hold candidate since Dec 20, 2017 Gain 16.48% PDF

No changes to the price of Inotek Pharmaceuticals Corporation fund on the last trading day (Monday, 22nd Jan 2018). During the last trading day the fund fluctuated 0% from a day low at $3.04 to a day high of $3.04. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 21.42% during the next 3 months and, with a 90% probability hold a price between $3.04 and $4.03 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ITEK Signals & Forecast

The Inotek Pharmaceuticals Corporation fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.04 and $2.69. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, January 04, 2018, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Inotek Pharmaceuticals Corporation fund

On the downside, the fund finds support just below today's level from accumulated volume at $2.61 and $2.48. There is a natural risk involved when a fund is testing a support level, since if this is broken, the fund then may fall to the next support level. In this case, Inotek Pharmaceuticals Corporation finds support just below today's level at $2.61. If this is broken, then the next support from accumulated volume will be at $2.48 and $2.47.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $2.88 (-5.42%) (This fund has low daily movements and this gives low risk. The RSI14 is 79 and this increases the risk substantially. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (ITEK) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Inotek Pharmaceuticals Corporation to open at $3.04, and during the day (based on 14 day Average True Range), to move between $2.95 and $3.13, which gives a possible trading interval of +/-$0.0867 (+/-2.85%) up or down from last closing price. If Inotek Pharmaceuticals Corporation takes out the full calculated possible swing range there will be an estimated 5.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.20 (5.26%) than the support at $2.61 (14.14%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Inotek Pharmaceuticals Corporation fund A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Inotek Pharmaceuticals Corporation fund to perform well in the short-term.

Current score: 3.450 Buy Candidate Unchanged

Predicted Opening Price for Inotek Pharmaceuticals Corporation of Tuesday, January 23, 2018

Fair opening price January 23, 2018 Current price
$3.04 ( 0.00000000%) $3.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ITEK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.04 0.00000000 %
R2 3.04 0.00000000 %
R1 3.04 0.00000000 %
Current price: 3.04
Support S1 3.04 0.00000000 %
S2 3.04 0.00000000 %
S3 3.04 0.00000000 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 3.20 5.26 %
Current price 3.04
Support S1 2.61 -14.14%
S2 2.48 -18.42%
S3 2.47 -18.75%

FAQ

What is the symbol for Inotek Pharmaceuticals Corporation Fund and on which exchange is it traded?
The symbol for Inotek Pharmaceuticals Corporation is ITEK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inotek Pharmaceuticals Corporation Fund?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Inotek Pharmaceuticals Corporation fund to perform well in the short-term.

How to buy Inotek Pharmaceuticals Corporation Fund?
Inotek Pharmaceuticals Corporation Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inotek Pharmaceuticals Corporation Fund.

What's the current price of Inotek Pharmaceuticals Corporation Fund?
As of the end of day on the 2018-01-22, the price of an Inotek Pharmaceuticals Corporation (ITEK) share was $3.04.

What is the 52-week high and low for Inotek Pharmaceuticals Corporation Fund?
The 52-week high for Inotek Pharmaceuticals Corporation Fund is $3.80 and the 52-week low is $0.85.
Click to get the best stock tips daily for free!

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The companyÂ’s lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eyeÂ’s natural pressure control mechanism. It is also developing Trabodenoson plus La... ITEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT